Author:
Topaloglu Rezan,Levart Tanja Kersnik,Nagata Michio,Avcin Tadej
Publisher
Springer International Publishing
Reference106 articles.
1. Avcin T, O’Neil KM. Antiphospholipid syndrome. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, editors. Textbook of rheumatology. 7th ed. Philadelphia: Elsevier; 2016. p. 318–35.
2. Avcin T, Ambrozic A, Kuhar M, Kveder T, Rozman B. Anticardiolipin and anti-beta(2) glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits. Rheumatology (Oxford). 2001;40(5):565–73. https://doi.org/10.1093/rheumatology/40.5.565.
3. Avcin T, Cimaz R, Meroni PL. Do we need an international consensus statement on classification criteria for the antiphospholipid syndrome in the paediatric population? Lupus. 2001;10(12):897–8. https://doi.org/10.1191/096120301701548427.
4. Avcin T, Ambrozic A, Bozic B, Accetto M, Kveder T, Rozman B. Estimation of anticardiolipin antibodies, anti-beta2 glycoprotein I antibodies and lupus anticoagulant in a prospective longitudinal study of children with juvenile idiopathic arthritis. Clin Exp Rheumatol. 2002;20(1):101–8.
5. Avcin T, Cimaz R, Silverman ED, Cervera R, Gattorno M, Garay S, et al. Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry. Pediatrics. 2008;122(5):e1100–7. https://doi.org/10.1542/peds.2008-1209.